About Mercator MedSystems
Mercator MedSystems is a company based in San Leandro (United States) founded in 2000. Mercator MedSystems has raised $31.8 million across 5 funding rounds from investors including HHS, Shenzhen Xinlitai Pharmaceutical and Volcano Capital Management. Mercator MedSystems offers products and services including Bullfrog Micro-Infusion Device. Mercator MedSystems operates in a competitive market with competitors including BridgeBio, Spark Therapeutics, Insulet, Alnylam and ATAI, among others.
- Headquarter San Leandro, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Mercator Medsystems, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$31.8 M (USD)
in 5 rounds
-
Latest Funding Round
$14.3 M (USD), Series D
Jun 17, 2019
-
Investors
HHS
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Mercator MedSystems
Mercator MedSystems offers a comprehensive portfolio of products and services, including Bullfrog Micro-Infusion Device.
Delivers drugs directly to vessel walls for targeted vascular treatments.
People of Mercator MedSystems
Unlock access to complete
Unlock access to complete
Funding Insights of Mercator MedSystems
Mercator MedSystems has successfully raised a total of $31.8M across 5 strategic funding rounds. The most recent funding activity was a Series D round of $14.3 million completed in June 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Mercator MedSystems
Mercator MedSystems has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Shenzhen Xinlitai Pharmaceutical and Volcano Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Tech and life sciences focused VC firm investing in geographies such as the US
|
Locked | Locked | Locked |
Investor details for Mercator MedSystems
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Mercator MedSystems
Investment portfolio details for Mercator MedSystems
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Mercator MedSystems
Detailed financials for Mercator MedSystems
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mercator Medsystems Comparisons
Peer comparison for Mercator MedSystems
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Mercator MedSystems
Mercator MedSystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BridgeBio, Spark Therapeutics, Insulet, Alnylam and ATAI, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| Locked | Locked | Locked |
Wearable insulin infusion systems are developed for diabetes patients.
|
|
| Locked | Locked | Locked |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| Locked | Locked | Locked |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
Detailed competitors of Mercator MedSystems
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mercator Medsystems
Complete news archive for Mercator MedSystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mercator MedSystems
Mercator MedSystems was founded in 2000 and raised its 1st funding round 9 years after it was founded.
Mercator MedSystems is headquartered in San Leandro, United States. It is registered at San Leandro, California, United States.
Mercator MedSystems is a funded company, having raised a total of $31.8M across 5 funding rounds to date.
Mercator MedSystems was founded in 2000 and is based in San Leandro, United States. Micro-infusion catheters are developed by the company for non-systemic injection of therapeutic agents through blood vessel walls into deep tissues. These systems support applications in plaque stabilization for diseased vessels, anti-tumor drug delivery, growth factor administration for cell stimulation, and stem cell or gene therapies. Operations focus on vascular diseases, hypertension, oncology, and regenerative medicine sectors.
Mercator MedSystems's top competitors include Spark Therapeutics, BridgeBio and Insulet.
Mercator MedSystems offers Bullfrog Micro-Infusion Device.
Mercator MedSystems has 5 investors. Key investors include HHS, Shenzhen Xinlitai Pharmaceutical, Volcano Capital Management, Crocker Capital, and Aphelion Capital.